Heffernan Michael Thomas bought TRVI
September 15, 2026 · Form 4 insider transaction
Heffernan Michael Thomas bought 21,052 shares of Trevi Therapeutics, Inc. at $3.33 per share, a transaction worth $70.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,052
Price
$3.33
Total value
$70.1K
InsiderHeffernan Michael Thomas
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after27,403
OwnershipDirect
10b5-1 planNo
AmendedNo